Kamakura Mayuko, Fukuda Daisuke, Kuroishi Naho, Ainiwaer Dilinuer, Hattori Junko
Medical Affairs, MSD K.K., Tokyo, Japan.
IQVIA Solutions Japan K.K., Tokyo, Japan.
AIDS Patient Care STDS. 2023 May;37(5):253-267. doi: 10.1089/apc.2023.0013. Epub 2023 Apr 20.
We conducted a web-based survey targeting physicians in specialties of treating sexually transmitted infection (STI) and/or human immunodeficiency virus (HIV) patients to understand the current STI/HIV care practices and their acceptability of and barriers to the prescription of pre-exposure prophylaxis (PrEP) in Japan. A descriptive analysis was used to summarize survey responses. Univariate and multivariable logistic regression were performed to identify factors associated with willingness to prescribe PrEP. Of 316 survey respondents, 57 were specialized in HIV, 90 STI/Urology/Proctology, 55 Obstetrics/Gynecology, and 114 General Practice/Internal Medicine/Dermatology. Proportion of HIV-specialized physicians who interview the patients about risk behaviors tended to be higher than other physician groups (84.2% vs. 54.8%, 47.3%, and 50.9%, respectively), and 53 - 75% of non-HIV-specialized physicians reported that they were incapable of making decisions on HIV medications. Higher PrEP knowledge enhanced the willingness to recommend and prescribe PrEP drugs (odds ratio: 2.31, 95% confidence interval: 1.30-4.10, = 0.0044), and 45.4% physicians with no PrEP knowledge raised the concern of incapability to respond and manage when an individual is infected with HIV. Educational opportunities on management and prevention measures for both STI and HIV may encourage non-HIV-specialized physicians to be involved in HIV care and to enhance initiation of HIV tests and adoption of PrEP.
我们针对治疗性传播感染(STI)和/或人类免疫缺陷病毒(HIV)患者的专科医生开展了一项基于网络的调查,以了解日本目前的性传播感染/艾滋病护理实践,以及他们对暴露前预防(PrEP)处方的接受程度和障碍。采用描述性分析来总结调查回复。进行单变量和多变量逻辑回归以确定与开具PrEP意愿相关的因素。在316名调查受访者中,57名是HIV专科医生,90名是性传播感染/泌尿外科/直肠科医生,55名是妇产科医生,114名是全科/内科/皮肤科医生。询问患者风险行为的HIV专科医生比例往往高于其他医生群体(分别为84.2%对54.8%、47.3%和50.9%),53%-75%的非HIV专科医生表示他们无法就HIV药物做出决策。较高的PrEP知识增强了推荐和开具PrEP药物的意愿(优势比:2.31,95%置信区间:1.30-4.10,P=0.0044),45.4%不具备PrEP知识的医生担心当个体感染HIV时无法应对和管理。性传播感染和HIV管理及预防措施的教育机会可能会鼓励非HIV专科医生参与HIV护理,并加强HIV检测的启动和PrEP的采用。